BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Nov 25, 2002
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Aton Pharma Inc.

Tarrytown, N.Y.

Technology: Therapeutics based on histone deacetylase inhibition

Disease focus: Cancer and neurodegenerative diseases

Read the full 73 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >